Supplier profile
GlaxoSmithKline, s.r.o.
Every public-sector award we hold for this supplier, across Czechia, from 4 Mar 2019 to 24 Jul 2026.
Awards won
100
all time
Attributed value
CZK 1.4bn
42 shared, unvalued
Buyers
20
public bodies
Active
2019–2026
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| Fakultní nemocnice Bulovka | 21 | CZK 573.7m |
| Fakultní nemocnice Brno | 15 | CZK 405.9m |
| Fakultní nemocnice Hradec Králové | 10 | CZK 32.4m |
| Nemocnice České Budějovice, a.s. | 9 | CZK 35.1m |
| Krajská zdravotní, a.s. | 7 | CZK 17.4m |
| Fakultní nemocnice Ostrava | 6 | not attributable |
| Fakultní nemocnice Plzeň | 6 | not attributable |
| Fakultní nemocnice Olomouc | 5 | CZK 24.6m |
| Ústřední vojenská nemocnice - Vojenská fakultní nemocnice Praha | 5 | CZK 123.9m |
| Masarykův onkologický ústav | 3 | CZK 166.3m |
What they win
Awards
Showing 76–100 of 100 awards we hold
- Czechia-České Budějovice: Medical preparations excluding dental consumables ↗Nemocnice České Budějovice, a.s.£3.5mawarded 23 Nov 2022
- Czechia-Ústí nad Labem: Antivirals for systemic use ↗Krajská zdravotní, a.s.£6.2mawarded 31 Oct 2022
- Czechia-Prague: Antivirals for systemic use ↗Fakultní nemocnice Bulovka£21.7mawarded 14 Oct 2022
- Czechia-Prague: Antivirals for systemic use ↗Ústřední vojenská nemocnice - Vojenská fakultní nemocnice Praha£44.8mawarded 16 Sept 2022
- Czechia-Hradec Králové: Antivirals for systemic use ↗Fakultní nemocnice Hradec Králové£31.7mawarded 19 Aug 2022
- Czechia-České Budějovice: Medical preparations excluding dental consumables ↗Nemocnice České Budějovice, a.s.£4.1mawarded 27 Jul 2022
- Czechia-Prague: Antivirals for systemic use ↗Fakultní nemocnice Bulovka£24.4mawarded 15 Jul 2022
- Czechia-Prague: Antivirals for systemic use ↗Fakultní nemocnice Bulovka£20.7mawarded 15 Apr 2022
- Czechia-Plzeň: Antineoplastic and immunomodulating agents ↗Fakultní nemocnice Plzeňshared awardawarded 24 Jan 2022
- Czechia-Hradec Králové: Antivirals for systemic use ↗Fakultní nemocnice Hradec Královéshared awardawarded 17 Jan 2022
- Czechia-Prague: Antivirals for systemic use ↗Ústřední vojenská nemocnice - Vojenská fakultní nemocnice Praha£19.9mawarded 12 Jan 2022
- Czechia-Prague: Antivirals for systemic use ↗Fakultní nemocnice Bulovka£5.3mawarded 29 Oct 2021
- Czechia-Brno: Pharmaceutical products ↗Fakultní nemocnice Brno£3.5mawarded 21 Jul 2021
- Czechia-Brno: Antivirals for systemic use ↗Fakultní nemocnice Brnoshared awardawarded 25 May 2021
- Czechia-Brno: Antivirals for systemic use ↗Fakultní nemocnice Brnoshared awardawarded 3 May 2021
- Czechia-Brno: Antivirals for systemic use ↗Fakultní nemocnice Brnoshared awardawarded 2 Feb 2021
- Czechia-Brno: Antivirals for systemic use ↗Fakultní nemocnice Brnoshared awardawarded 30 Oct 2020
- Czechia-Ústí nad Labem: Antivirals for systemic use ↗Krajská zdravotní, a.s.£2.2mawarded 10 Aug 2020
- Czechia-Brno: Antivirals for systemic use ↗Fakultní nemocnice Brnoshared awardawarded 24 Jul 2020
- Czechia-Ústí nad Labem: Antivirals for systemic use ↗Krajská zdravotní, a.s.£8.3mawarded 7 Feb 2020
- Czechia-Brno: Antivirals for systemic use ↗Fakultní nemocnice Brnoshared awardawarded 25 Oct 2019
- Czechia-Brno: Antivirals for systemic use ↗Fakultní nemocnice Brnoshared awardawarded 23 Apr 2019
- Czechia-Ostrava: Pharmaceutical products ↗Fakultní nemocnice Ostravashared awardawarded 19 Apr 2019
- Czechia-Hradec Králové: Antivirals for systemic use ↗Fakultní nemocnice Hradec Královéshared awardawarded 19 Mar 2019
- Czech Republic-Brno: Antivirals for systemic use ↗Fakultní nemocnice Brno£92.1mawarded 4 Mar 2019
Possibly the same organisation
These entries differ from this one only by legal form or a bracketed qualifier, so they may be the same organisation — or a different registered company of the same name. They are kept apart on purpose: the figures on each page are per legal entity and are never combined.
- Glaxosmithkline542 awards · £2.2m
- GLAXOSMITHKLINE, S.A.971 awards
- GlaxoSmithKline Inc.493 awards
- GLAXOSMITHKLINE S.P.A.318 awards
- GLAXOSMITHKLINE, LLC309 awards
- GlaxoSmithKline GmbH & Co. KG84 awards
- GlaxoSmithKline AB80 awards
- GlaxoSmithKline (GSK) SRL45 awards
- GlaxoSmithKline Oy31 awards
- GlaxoSmithKline BV19 awards
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.